Quick Answer
NewGenIvf Group Ltd reported Total Revenue of $4.73 million for fiscal year 2025.
NewGenIvf Group Ltd — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $4.73M -13.0% |
$5.43M +5.8% |
$5.14M -13.6% |
$5.94M +44.3% |
$4.12M | — |
| Net Income | $9.88M +1983.1% |
-$524.6K -503.0% |
$130.2K -71.6% |
$458.7K +86153.8% |
-$533.00 | — |
| Diluted EPS | $3.04 +100.1% |
-$4408.76 -133.9% |
$13019.30 +275732.6% |
$4.72 | $0.00 | — |
| Total Assets | $32.72M +814.6% |
$3.58M -20.3% |
$4.49M +54.5% |
$2.90M | — | — |
| Cash and Equivalents | $758.6K +65.7% |
$457.7K +746.0% |
$54.1K +96.3% |
$27.6K | — | — |
| Stockholders Equity | $26.63M +2639.7% |
-$1.05M -128.1% |
$3.74M +563.4% |
$563.1K +161.5% |
-$914.9K +7.0% |
-$984.1K |
| Operating Income | -$10.73M -824.3% |
-$1.16M -2847.3% |
$42.2K -89.4% |
$398.7K +100.6% |
$198.8K | — |
| Gross Profit | $955.8K -47.7% |
$1.83M +8.6% |
$1.68M +9.4% |
$1.54M +50.1% |
$1.02M | — |
| Shares Outstanding | 240,622 +63221.6% |
380 -99.9% |
507,469 -15.7% |
601,830 | — | — |
- NewGenIvf Group Ltd reported Total Revenue of $4.73 million for fiscal year 2025.
- NewGenIvf Group Ltd showed a decrease of -13.0% in Total Revenue compared to the prior fiscal year.
- NewGenIvf Group Ltd reported Net Income of $9.88 million for fiscal year 2025.
- NewGenIvf Group Ltd showed an increase of +1983.1% in Net Income compared to the prior fiscal year.
- NewGenIvf Group Ltd reported Diluted EPS of $3.04 per share for fiscal year 2025.
- NewGenIvf Group Ltd showed an increase of +100.1% in Diluted EPS compared to the prior fiscal year.
- NewGenIvf Group Ltd reported Total Assets of $32.72 million for fiscal year 2025.
- NewGenIvf Group Ltd showed an increase of +814.6% in Total Assets compared to the prior fiscal year.
- NewGenIvf Group Ltd reported Cash and Equivalents of $758.6 thousand for fiscal year 2025.
- NewGenIvf Group Ltd showed an increase of +65.7% in Cash and Equivalents compared to the prior fiscal year.
- NewGenIvf Group Ltd reported Stockholders Equity of $26.63 million for fiscal year 2025.
- NewGenIvf Group Ltd showed an increase of +2639.7% in Stockholders Equity compared to the prior fiscal year.
- NewGenIvf Group Ltd reported Operating Income of -$10.73 million for fiscal year 2025.
- NewGenIvf Group Ltd showed a decrease of -824.3% in Operating Income compared to the prior fiscal year.
- NewGenIvf Group Ltd reported Gross Profit of $955.8 thousand for fiscal year 2025.
- NewGenIvf Group Ltd showed a decrease of -47.7% in Gross Profit compared to the prior fiscal year.
- NewGenIvf Group Ltd reported Shares Outstanding of 240.6 thousand shares for fiscal year 2025.
- NewGenIvf Group Ltd showed an increase of +63221.6% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: